Auro Impex & Chemicals Ltd

Auro Impex & Chemicals Ltd

₹ 84.1 -4.27%
22 Jul - close price
About

Incorporated in 1994, Auro Impex & Chemicals is engaged in manufacturing, exporting, and supply of Discharge & Collecting Electrodes, and Electrostatic Precipitator (ESP) internal parts and spares.[1]

Key Points

Product Portfolio[1] Company manufactures Collecting Electrodes of all profiles, Discharge Electrodes, Electromagnetic rapper, Tank Fabrication and Duct Fabrication, and other ESP Internal spare parts, for Original Equipment manufacturers (OEMs) and service providers ranging from sourcing components, designing, manufacturing, quality testing as per OEM specifications

  • Market Cap 103 Cr.
  • Current Price 84.1
  • High / Low 118 / 59.2
  • Stock P/E 17.7
  • Book Value 29.7
  • Dividend Yield 0.00 %
  • ROCE 23.2 %
  • ROE 46.4 %
  • Face Value 10.0

Pros

  • Company has delivered good profit growth of 90.8% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 47.7%
  • Debtor days have improved from 31.5 to 19.9 days.
  • Company's working capital requirements have reduced from 74.4 days to 57.2 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Sep 2023 Mar 2024
95 133 110
89 127 105
Operating Profit 6 6 5
OPM % 6% 4% 5%
0 0 0
Interest 1 2 2
Depreciation 0 0 0
Profit before tax 4 5 4
Tax % 28% 28% 31%
3 3 2
EPS in Rs 2.75 2.01
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
36 37 74 110 181 243
34 35 71 106 171 233
Operating Profit 2 2 3 4 10 11
OPM % 7% 5% 4% 4% 6% 4%
0 0 0 1 0 1
Interest 2 2 1 2 2 3
Depreciation 0 0 0 0 0 0
Profit before tax 0 0 1 3 8 8
Tax % 18% 10% 3% 26% 28% 29%
0 0 1 2 6 6
EPS in Rs 4.76
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 46%
3 Years: 49%
TTM: 34%
Compounded Profit Growth
10 Years: %
5 Years: 91%
3 Years: 86%
TTM: 4%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 39%
Return on Equity
10 Years: %
5 Years: 40%
3 Years: 48%
Last Year: 46%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 1 1 1 1 9 12
Reserves 3 3 4 6 3 24
18 17 16 27 37 29
9 8 13 14 11 12
Total Liabilities 31 28 34 48 60 77
7 6 6 8 9 9
CWIP 0 0 1 1 3 6
Investments 0 0 0 0 0 0
25 22 27 39 49 62
Total Assets 31 28 34 48 60 77

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 4 1 -3 -5 3
-0 -0 -1 -3 -3 -4
-1 -3 0 7 7 8
Net Cash Flow -0 0 -0 1 -0 7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 103 72 65 48 27
Inventory Days 110 113 47 61 51
Days Payable 91 76 55 25 4
Cash Conversion Cycle 122 110 58 84 74
Working Capital Days 155 135 73 89 77
ROCE % 9% 12% 17% 24%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024
71.55% 71.55%
0.22% 0.00%
28.24% 28.45%
No. of Shareholders 1,3771,264

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls